Splenomegaly in Veterinary Patients: Imaging, Sampling, Bleeding Risk, and Surgical Decisions

At a Glance

Splenomegaly in veterinary patients presents a diagnostic and therapeutic challenge that crosses species boundaries. The spleen's role in filtration, immune surveillance, and hematopoiesis means enlargement can arise from infectious, inflammatory, neoplastic, congestive, or infiltrative processes. This article provides a cross-species framework for evaluating splenomegaly, selecting imaging modalities, assessing bleeding risk before sampling, and determining when surgical referral is warranted.

Diagnostic Imaging Modalities for Splenomegaly

Abdominal Radiography

Survey abdominal radiography provides initial assessment of splenic size, shape, and position. The normal canine spleen lies along the left body wall, while the feline spleen is more mobile and often located in the left cranial abdomen. Splenomegaly appears as increased opacity in the left cranial abdomen with caudal displacement of adjacent organs. The splenic silhouette may be visible as a soft tissue opacity with rounded margins.

Radiographic findings that suggest splenomegaly include loss of the normal splenic angle, extension of the spleen beyond the costal arch, and displacement of the gastric axis. In dogs, the splenic head normally sits at the level of the 11th to 13th ribs. Extension beyond the 13th rib or into the mid-abdomen indicates enlargement. The Merck Veterinary Manual provides reference for normal splenic anatomy and radiographic appearance across species.

Limitations of radiography include poor sensitivity for mild splenomegaly and inability to characterize parenchymal architecture. Radiography cannot distinguish between diffuse infiltration, congestion, or mass lesions. The technique is most useful as a screening tool or when ultrasound is unavailable.

Abdominal Ultrasonography

Ultrasound is the primary imaging modality for evaluating splenomegaly. It allows assessment of splenic size, echogenicity, parenchymal architecture, and vascular flow. Normal splenic parenchyma is homogeneous and slightly more echogenic than renal cortex. The splenic margin should be smooth, and the capsule should be visible as a thin hyperechoic line.

Ultrasound findings in splenomegaly include increased splenic thickness, rounded margins, and altered echogenicity. Diffuse splenomegaly may appear hypoechoic, hyperechoic, or mixed depending on the underlying cause. Mass lesions appear as focal areas of altered echogenicity that disrupt the normal parenchymal pattern. Doppler ultrasound evaluates vascular flow and can identify thrombus, torsion, or arteriovenous malformations.

The Journal of the American Veterinary Medical Association published early work on splenomegaly characterization, establishing ultrasound as a cornerstone of diagnostic evaluation. Ultrasound-guided sampling is the standard approach for obtaining cytologic or histologic specimens from the spleen.

Advanced Imaging: Computed Tomography and Magnetic Resonance Imaging

Computed tomography (CT) provides detailed cross-sectional anatomy of the spleen and surrounding structures. CT is superior to ultrasound for detecting splenic torsion, assessing vascular involvement, and staging neoplastic disease. Contrast-enhanced CT identifies perfusion deficits, thrombus, and mass enhancement patterns. CT is indicated when ultrasound findings are equivocal, when surgical planning requires detailed vascular anatomy, or when concurrent thoracic disease is suspected.

Magnetic resonance imaging (MRI) offers superior soft tissue contrast but is rarely necessary for splenic evaluation in veterinary patients. MRI may be useful for characterizing infiltrative diseases or when ultrasound and CT are inconclusive. The technique is limited by availability, cost, and the need for general anesthesia.

La Nouvelle presse medicale published early work on splenotomography, establishing the foundation for cross-sectional imaging of the spleen. Modern CT and MRI protocols for splenic evaluation are described in veterinary radiology textbooks and institutional guidelines.

Fine-Needle Aspiration and Biopsy Techniques

Fine-Needle Aspiration for Cytology

Fine-needle aspiration (FNA) is a minimally invasive technique for obtaining cytologic specimens from the spleen. The procedure is performed under ultrasound guidance using a 22- to 25-gauge needle attached to a 6- to 12-mL syringe. The needle is advanced into the splenic parenchyma or mass, and gentle suction is applied while moving the needle back and forth. Suction is released before withdrawing the needle to prevent aspiration of the sample into the syringe.

FNA is indicated for diffuse splenomegaly, suspected infiltrative disease, and characterization of mass lesions. Cytology can identify lymphoid hyperplasia, extramedullary hematopoiesis, mast cell infiltration, lymphoma, and metastatic neoplasia. The diagnostic yield depends on sample quality, cellularity, and the experience of the cytologist.

Limitations of FNA include inability to assess tissue architecture, risk of hemodilution, and potential for nondiagnostic samples. FNA cannot distinguish between benign and malignant spindle cell tumors because it does not provide information about capsular invasion or mitotic activity. The procedure carries a low but real risk of hemorrhage, particularly in patients with coagulopathy or thrombocytopenia.

Core Needle Biopsy for Histopathology

Core needle biopsy provides a tissue core for histopathologic evaluation. The procedure is performed under ultrasound guidance using a spring-loaded biopsy needle (14- to 18-gauge). The needle is advanced to the splenic capsule, and the biopsy is triggered to obtain a core of parenchyma. Multiple samples may be obtained from different regions of the spleen.

Core biopsy is indicated when cytology is nondiagnostic, when tissue architecture is needed for diagnosis, or when a mesenchymal tumor is suspected. Histopathology can distinguish between benign and malignant spindle cell tumors, characterize lymphoid neoplasia, and identify infiltrative diseases such as amyloidosis or myelofibrosis.

The risk of hemorrhage is higher with core biopsy than with FNA. Coagulation testing and platelet count should be performed before the procedure. The patient should be monitored for 24 hours after biopsy for signs of hemorrhage. The Journal of Veterinary Internal Medicine has published guidelines for splenic biopsy techniques and complication rates.

Contraindications and Precautions

Absolute contraindications to splenic sampling include uncorrectable coagulopathy, severe thrombocytopenia (platelet count below 50,000/µL), and hemodynamic instability. Relative contraindications include splenic torsion, suspected hemangiosarcoma with active hemorrhage, and patients with concurrent anticoagulant therapy.

Precautions include using the smallest needle gauge that will yield a diagnostic sample, limiting the number of passes, and applying direct pressure to the biopsy site after needle withdrawal. Ultrasound guidance should be used for all splenic sampling procedures to visualize the needle tip and avoid adjacent structures.

Bleeding Risk Assessment

Coagulation Testing

Bleeding risk assessment begins with a thorough history and physical examination. Historical findings that suggest increased bleeding risk include spontaneous bruising, epistaxis, hematuria, melena, and prolonged bleeding from previous venipuncture or surgical sites. Physical examination findings include petechiae, ecchymoses, and mucosal hemorrhage.

Laboratory evaluation includes prothrombin time (PT), activated partial thromboplastin time (aPTT), platelet count, and buccal mucosal bleeding time (BMBT). PT and aPTT assess the extrinsic and intrinsic coagulation pathways. Platelet count should be above 100,000/µL for safe sampling. BMBT evaluates platelet function and is prolonged in thrombocytopenia, von Willebrand disease, and platelet dysfunction.

The Merck Veterinary Manual provides reference ranges for coagulation parameters across species. Abnormal results should be interpreted in the context of the patient's signalment, history, and clinical presentation.

Platelet Count and Function

Thrombocytopenia is a common finding in patients with splenomegaly. The spleen sequesters platelets, and splenic enlargement increases the sequestered pool. Immune-mediated thrombocytopenia may accompany immune-mediated hemolytic anemia or systemic lupus erythematosus. Thrombocytopenia also occurs with disseminated intravascular coagulation, bone marrow suppression, and certain infectious diseases.

Platelet function testing is indicated when the platelet count is normal but there is clinical evidence of bleeding. BMBT is the most practical point-of-care test for platelet function. Prolonged BMBT in the face of normal platelet count suggests von Willebrand disease, platelet dysfunction, or vascular abnormality.

von Willebrand Factor Assessment

von Willebrand factor (vWF) is a multimeric glycoprotein that mediates platelet adhesion to subendothelial collagen. Deficiency or dysfunction of vWF causes von Willebrand disease, the most common inherited bleeding disorder in dogs. Breeds at increased risk include Doberman Pinschers, German Shepherd Dogs, Golden Retrievers, and Scottish Terriers.

vWF testing is indicated before splenic sampling in at-risk breeds or when there is a history of bleeding. The test measures vWF antigen concentration in plasma. Results are reported as a percentage of normal, with values below 50% indicating deficiency. The American College of Veterinary Anesthesia and Analgesia provides guidelines for perioperative coagulation management in veterinary patients.

Splenectomy Indications and Surgical Decisions

Emergency Splenectomy

Emergency splenectomy is indicated for splenic torsion, traumatic splenic rupture, and hemoabdomen from splenic mass rupture. Splenic torsion occurs when the spleen rotates on its vascular pedicle, causing venous occlusion, congestion, and infarction. The condition is most common in large-breed dogs with deep chests, such as Great Danes and German Shepherd Dogs. The Journal of Small Animal Practice published a case series describing the clinical presentation and surgical management of splenic torsion.

Traumatic splenic rupture occurs with blunt abdominal trauma, such as vehicular trauma or falls. The spleen is the most commonly injured organ in abdominal trauma. Emergency splenectomy is indicated when hemorrhage is uncontrolled and the patient is hemodynamically unstable.

Hemoabdomen from splenic mass rupture is a surgical emergency. The most common cause is hemangiosarcoma, a malignant vascular tumor that is highly metastatic. Emergency splenectomy is performed to control hemorrhage and obtain a definitive diagnosis. The patient should be stabilized with intravenous fluids and blood products before surgery.

Elective Splenectomy

Elective splenectomy is indicated for splenic masses that are benign but cause clinical signs, such as pain, discomfort, or gastrointestinal obstruction. Benign splenic masses include hematomas, nodular hyperplasia, and myelolipomas. Elective splenectomy is also indicated for splenic abscesses that do not respond to medical therapy.

Splenectomy may be indicated for immune-mediated diseases that are refractory to medical management. Immune-mediated hemolytic anemia and immune-mediated thrombocytopenia may respond to splenectomy by removing the primary site of red blood cell or platelet destruction. The decision to perform splenectomy for immune-mediated disease should be made in consultation with a veterinary internist.

Surgical Referral Criteria

Referral to a veterinary surgeon is indicated when the general practitioner is not comfortable performing splenectomy, when the mass is large or adherent to adjacent structures, or when there is concern for metastatic disease. Referral is also indicated when the patient has concurrent medical conditions that increase anesthetic risk, such as cardiac disease, renal failure, or coagulopathy.

The American Animal Hospital Association provides guidelines for surgical referral and perioperative management. Referral should be considered when the anticipated blood loss exceeds 20% of blood volume, when the mass is located at the splenic hilus, or when there is evidence of vascular invasion.

Common Failure Patterns in Splenomegaly Management

Diagnostic Delay

Delayed diagnosis of splenomegaly occurs when the condition is not recognized on physical examination or when imaging is not performed. The spleen may be difficult to palpate in obese patients or in patients with tense abdominal musculature. Splenomegaly may be mistaken for other abdominal masses, such as renal or hepatic enlargement.

Diagnostic delay is more common in cats than in dogs because the feline spleen is more mobile and may be located in the right abdomen. The Merck Veterinary Manual notes that splenomegaly in cats is often detected incidentally during abdominal ultrasound for other indications.

Inadequate Sampling

Inadequate sampling occurs when the needle does not enter the splenic parenchyma, when the sample is hemodiluted, or when the sample is too small for cytologic or histologic evaluation. Inadequate sampling is more common with FNA than with core biopsy because FNA yields only cells, not tissue architecture.

Strategies to improve sampling include using ultrasound guidance, obtaining multiple samples from different regions, and having a cytologist or pathologist review the sample immediately for adequacy. The Journal of Veterinary Internal Medicine has published recommendations for optimizing splenic sampling techniques.

Hemorrhagic Complications

Hemorrhagic complications occur when the spleen is sampled in a patient with coagulopathy, when the needle lacerates a splenic vessel, or when the biopsy site is not adequately compressed. Hemorrhage may be intra-abdominal or subcutaneous. Intra-abdominal hemorrhage is more serious and may require surgical intervention.

Prevention of hemorrhagic complications includes performing coagulation testing before sampling, using the smallest needle gauge that will yield a diagnostic sample, and applying direct pressure to the biopsy site for at least five minutes after needle withdrawal. The patient should be monitored for 24 hours after sampling for signs of hemorrhage, such as tachycardia, hypotension, and abdominal distension.

Records and Measurements

Splenic Size Documentation

Splenic size should be documented in the medical record using objective measurements. Ultrasound measurements include splenic length, width, and thickness. Normal splenic thickness in dogs is less than 1.5 cm, and in cats is less than 1.0 cm. Splenic length varies with body size and breed.

Serial measurements are useful for monitoring disease progression or response to therapy. The same imaging modality and measurement technique should be used for each assessment to ensure consistency. The Journal of the American Veterinary Medical Association has published reference ranges for splenic size in dogs and cats.

Coagulation Panel Documentation

Coagulation panel results should be documented in the medical record before splenic sampling. The panel should include PT, aPTT, platelet count, and BMBT. Results should be interpreted in the context of the patient's signalment, history, and clinical presentation.

Abnormal results should be investigated before proceeding with sampling. Causes of abnormal coagulation include liver disease, vitamin K deficiency, disseminated intravascular coagulation, and inherited coagulation disorders. The Merck Veterinary Manual provides guidance for interpreting coagulation test results.

Surgical Findings Documentation

Surgical findings should be documented in the medical record, including splenic size, shape, color, and consistency. The presence of masses, adhesions, or torsion should be noted. The surgical technique used for splenectomy should be described, including the method of vascular ligation.

Histopathologic findings should be documented in the medical record, including the diagnosis, tumor grade, and margin status. The World Organisation for Animal Health provides guidelines for reporting histopathologic findings in veterinary patients.

Welfare and Safety Context

Pain Management

Splenomegaly may cause abdominal pain, particularly when the splenic capsule is stretched or when there is splenic infarction. Pain should be assessed using a validated pain scoring system, such as the Glasgow Composite Measure Pain Scale or the Colorado State University Feline Acute Pain Scale.

Analgesia should be provided before and after splenic sampling or surgery. Multimodal analgesia, including opioids, nonsteroidal anti-inflammatory drugs, and local anesthetics, is recommended. The American College of Veterinary Anesthesia and Analgesia provides guidelines for perioperative pain management.

Anesthetic Considerations

Anesthetic management of patients with splenomegaly requires careful consideration of the underlying disease and the planned procedure. Patients with hemoabdomen are hemodynamically unstable and require aggressive fluid resuscitation before anesthesia. Patients with splenic torsion may have electrolyte abnormalities and acid-base disturbances.

Anesthetic drugs should be selected based on the patient's cardiovascular status. Propofol and sevoflurane are commonly used for induction and maintenance of anesthesia. Ketamine may be used for patients with hypotension. The American Animal Hospital Association provides guidelines for anesthetic management of veterinary patients.

Postoperative Monitoring

Postoperative monitoring after splenectomy includes assessment of vital signs, pain scores, and surgical site integrity. Patients should be monitored for signs of hemorrhage, such as tachycardia, hypotension, and abdominal distension. The surgical site should be inspected for swelling, discharge, or dehiscence.

Patients should be monitored for signs of pancreatitis, which can occur after splenectomy due to manipulation of the pancreatic tail. Clinical signs of pancreatitis include vomiting, anorexia, and abdominal pain. Serum amylase and lipase should be measured if pancreatitis is suspected.

Practical Decision Framework for Splenomegaly Management: A Stepwise Clinical Algorithm

Clinical Decision Algorithm for Splenic Evaluation

A structured decision framework helps clinicians navigate the diagnostic and therapeutic options for splenomegaly across species. The following algorithm integrates imaging findings, clinical presentation, and risk assessment to guide management decisions.

Step 1: Initial Clinical Assessment

Begin with a complete history and physical examination. Palpate the spleen in both lateral and dorsal recumbency. Document splenic size, shape, consistency, and mobility. Note any pain on palpation, which may indicate capsular stretching, infarction, or torsion. Record the patient's signalment, as breed predispositions influence differential diagnoses. Large-breed dogs with deep chests are at increased risk for splenic torsion, while certain breeds have higher prevalence of hemangiosarcoma or von Willebrand disease.

Assess for systemic signs including fever, lethargy, weight loss, pallor, icterus, and lymphadenopathy. The presence of petechiae or ecchymoses suggests thrombocytopenia or coagulopathy. Abdominal distension or fluid wave indicates possible hemoabdomen or ascites.

Step 2: Triage for Emergency vs. Non-Emergency

Determine if the patient requires emergency intervention. Emergency criteria include:

• Hemodynamic instability (tachycardia, hypotension, pale mucous membranes, prolonged capillary refill time)
• Acute abdominal distension suggesting hemoabdomen
• Evidence of splenic torsion (acute severe pain, vomiting, collapse)
• Traumatic injury with suspected splenic rupture

Patients meeting emergency criteria require immediate stabilization with intravenous fluids, blood product availability, and surgical consultation. The American College of Veterinary Anesthesia and Analgesia provides guidelines for emergency stabilization of hemodynamically compromised patients.

Non-emergency patients proceed to diagnostic imaging and laboratory evaluation.

Step 3: Diagnostic Imaging Selection

Choose imaging based on clinical presentation and available resources.

For patients with suspected hemoabdomen or trauma, perform focused assessment with sonography in trauma (FAST) to detect free abdominal fluid. FAST is a rapid, point-of-care ultrasound protocol that evaluates four abdominal quadrants for fluid accumulation. Positive FAST indicates hemoabdomen and warrants emergency surgical exploration.

For stable patients with palpable splenomegaly, abdominal ultrasound is the first-line imaging modality. Ultrasound provides real-time assessment of splenic size, echogenicity, parenchymal architecture, and vascular flow. Document the following ultrasound parameters:

• Splenic length, width, and thickness
• Parenchymal echogenicity (hypoechoic, hyperechoic, mixed)
• Presence and characteristics of mass lesions (size, shape, margins, echogenicity)
• Vascular flow on Doppler examination
• Presence of free abdominal fluid
• Evaluation of other abdominal organs for metastatic disease or concurrent abnormalities

If ultrasound is unavailable or inconclusive, survey abdominal radiography provides initial assessment of splenic size and position. Radiographic findings suggestive of splenomegaly include loss of the normal splenic angle, extension beyond the costal arch, and displacement of adjacent organs.

Advanced imaging with computed tomography (CT) is indicated when:

• Ultrasound findings are equivocal
• Surgical planning requires detailed vascular anatomy
• Splenic torsion is suspected but not confirmed on ultrasound
• Concurrent thoracic disease is suspected (three-view thoracic radiographs or CT)
• Staging for neoplastic disease is needed

The Journal of the American Veterinary Medical Association has published guidelines for imaging modality selection in splenic disease.

Step 4: Laboratory Evaluation and Bleeding Risk Assessment

Before any splenic sampling, perform baseline laboratory evaluation including:

• Complete blood count with platelet count
• Serum biochemistry profile
• Coagulation panel (prothrombin time, activated partial thromboplastin time)
• Buccal mucosal bleeding time (BMBT)
• von Willebrand factor antigen in at-risk breeds

Interpret laboratory results using established reference ranges from the Merck Veterinary Manual. Platelet count should be above 100,000/µL for safe sampling. BMBT should be within normal limits for the species. Abnormal coagulation parameters require investigation before proceeding with sampling.

Document all laboratory results in the medical record with interpretation and plan for abnormal findings.

Step 5: Sampling Decision

Based on imaging findings and laboratory results, determine the appropriate sampling technique.

For diffuse splenomegaly without discrete mass lesions, fine-needle aspiration (FNA) for cytology is the initial sampling method. FNA is indicated for suspected infiltrative diseases such as lymphoma, mast cell infiltration, extramedullary hematopoiesis, or lymphoid hyperplasia.

For discrete mass lesions, consider the following:

• Masses with benign ultrasound characteristics (smooth margins, homogeneous echogenicity, no vascular invasion) may be sampled by FNA or core biopsy
• Masses with malignant ultrasound characteristics (irregular margins, heterogeneous echogenicity, vascular invasion, necrotic centers) require histopathology for definitive diagnosis
• Suspected mesenchymal tumors (hemangiosarcoma, fibrosarcoma) require core biopsy or surgical excision for accurate diagnosis

Core needle biopsy is indicated when:

• FNA is nondiagnostic
• Tissue architecture is needed for diagnosis
• Mesenchymal tumor is suspected
• Cytology suggests but cannot confirm malignancy

Contraindications to sampling include uncorrectable coagulopathy, severe thrombocytopenia (platelet count below 50,000/µL), and hemodynamic instability.

Step 6: Procedure Performance and Monitoring

Perform ultrasound-guided sampling using aseptic technique. For FNA, use a 22- to 25-gauge needle attached to a 6- to 12-mL syringe. Advance the needle into the splenic parenchyma or mass, apply gentle suction while moving the needle back and forth, release suction before withdrawal, and apply direct pressure to the puncture site for at least five minutes.

For core biopsy, use a spring-loaded biopsy needle (14- to 18-gauge). Advance the needle to the splenic capsule, trigger the biopsy, and withdraw. Obtain multiple samples from different regions if possible. Apply direct pressure to the biopsy site for at least five minutes.

Monitor the patient for 24 hours after sampling for signs of hemorrhage including tachycardia, hypotension, abdominal distension, and decreased packed cell volume. Document vital signs every 4 hours for the first 12 hours, then every 6 hours for the next 12 hours.

Step 7: Interpretation and Management Plan

Submit samples for cytologic or histopathologic evaluation. Interpret results in the context of clinical presentation and imaging findings.

For benign diagnoses (nodular hyperplasia, extramedullary hematopoiesis, hematoma), management options include:

• Monitoring with serial ultrasound every 3 to 6 months
• Elective splenectomy if the mass is large or causing clinical signs
• Medical management of underlying disease if identified

For malignant diagnoses (hemangiosarcoma, lymphoma, mast cell tumor), management options include:

• Staging for metastatic disease (thoracic radiographs or CT, abdominal ultrasound, lymph node evaluation)
• Surgical consultation for splenectomy
• Oncology consultation for chemotherapy or other adjunctive therapy
• Discussion of prognosis and treatment options with the owner

For infectious or inflammatory diagnoses, manage the underlying cause with appropriate antimicrobial or immunosuppressive therapy.

Step 8: Surgical Referral Decision

Refer to a veterinary surgeon when:

• Splenectomy is indicated but the general practitioner is not comfortable performing the procedure
• The mass is large, adherent to adjacent structures, or located at the splenic hilus
• There is concern for metastatic disease requiring extensive surgical exploration
• The patient has concurrent medical conditions that increase anesthetic risk
• Anticipated blood loss exceeds 20% of blood volume
• Vascular invasion is present on imaging

The American Animal Hospital Association provides guidelines for surgical referral and perioperative management.

Record System for Splenomegaly Cases

A standardized record system ensures consistent documentation and facilitates monitoring of disease progression or response to therapy. The following template captures essential information for each splenomegaly case.

Patient Information

• Signalment (species, breed, age, sex, weight)
• Presenting complaint and duration
• Relevant medical history (previous illnesses, medications, surgeries)
• Breed-specific risk factors (von Willebrand disease, hemangiosarcoma predisposition)

Physical Examination Findings

• Splenic palpation findings (size, shape, consistency, mobility, pain)
• Abdominal palpation findings (masses, organomegaly, fluid wave, pain)
• Mucous membrane color and capillary refill time
• Heart rate, respiratory rate, temperature
• Body condition score
• Presence of petechiae, ecchymoses, or other bleeding signs

Diagnostic Imaging Findings

• Imaging modality used (radiography, ultrasound, CT, MRI)
• Splenic measurements (length, width, thickness)
• Parenchymal characteristics (echogenicity, homogeneity, architecture)
• Mass lesion characteristics (size, shape, margins, echogenicity, vascularity)
• Vascular flow assessment (Doppler findings)
• Presence of free abdominal fluid
• Evaluation of other abdominal organs
• Thoracic imaging findings if performed

Laboratory Results

• Complete blood count (including platelet count)
• Serum biochemistry profile
• Coagulation panel (PT, aPTT)
• Buccal mucosal bleeding time
• von Willebrand factor antigen (if indicated)
• Other relevant tests (infectious disease serology, flow cytometry)

Sampling Information

• Sampling technique (FNA, core biopsy, surgical excision)
• Needle gauge and number of passes
• Sample quality assessment (cellularity, hemodilution, adequacy)
• Complications during or after sampling
• Post-sampling monitoring findings

Diagnostic Results

• Cytology or histopathology diagnosis
• Tumor grade and margin status (if applicable)
• Immunohistochemistry results (if performed)
• Staging results (if applicable)

Management Plan

• Medical therapy (drug, dose, frequency, duration)
• Surgical plan (elective vs. emergency, referral vs. in-house)
• Monitoring schedule (imaging, laboratory, physical examination)
• Owner communication and consent documentation
• Prognosis discussion

Follow-up Documentation

• Date and findings of each follow-up visit
• Serial splenic measurements
• Response to therapy
• Complications or adverse events
• Changes in management plan

Troubleshooting Common Clinical Scenarios

Scenario 1: Nondiagnostic FNA

If FNA yields a nondiagnostic sample (hemodiluted, acellular, or insufficient cells), consider the following:

• Repeat FNA with a larger needle gauge (22-gauge instead of 25-gauge)
• Obtain samples from multiple regions of the spleen or mass
• Use a different technique (capillary sampling without suction may reduce hemodilution)
• Proceed to core needle biopsy for histopathology
• Consider surgical excision if the mass is large or suspicious for malignancy

Document the reason for nondiagnostic sample and the plan for obtaining a definitive diagnosis.

Scenario 2: Coagulopathy Identified Before Sampling

If coagulation testing reveals abnormalities, do not proceed with splenic sampling until the coagulopathy is corrected or the risk is fully assessed.

For thrombocytopenia (platelet count below 100,000/µL):

• Investigate the cause (immune-mediated, infectious, drug-induced, bone marrow suppression)
• Consider platelet transfusion if sampling is urgent
• Postpone elective sampling until platelet count improves

For prolonged PT or aPTT:

• Investigate the cause (liver disease, vitamin K deficiency, disseminated intravascular coagulation, anticoagulant rodenticide toxicity)
• Administer vitamin K if deficiency is suspected
• Consider fresh frozen plasma transfusion if sampling is urgent

For prolonged BMBT:

• Investigate for von Willebrand disease or platelet dysfunction
• Administer desmopressin (DDAVP) in von Willebrand disease
• Consider cryoprecipitate transfusion if sampling is urgent

Document the coagulopathy, its investigation, and the management plan before proceeding with sampling.

Scenario 3: Hemorrhage After Sampling

If hemorrhage occurs after splenic sampling, take immediate action:

• Apply direct pressure to the puncture site for at least 10 minutes
• Assess the patient for signs of hemodynamic instability (tachycardia, hypotension, pale mucous membranes)
• Perform repeat ultrasound to assess for free abdominal fluid
• Monitor packed cell volume and total solids every 2 to 4 hours
• Administer intravenous fluids and blood products as needed
• Consider surgical exploration if hemorrhage is uncontrolled

Document the hemorrhage, its severity, and the interventions performed.

Scenario 4: Incidental Splenomegaly on Imaging

If splenomegaly is detected incidentally on imaging performed for other indications, follow the algorithm:

• Perform complete physical examination with specific attention to splenic palpation
• Obtain baseline laboratory evaluation including complete blood count and serum biochemistry
• Assess for clinical signs referable to splenic disease
• Consider FNA if the spleen is diffusely enlarged or if a mass is present
• Monitor with serial ultrasound if no abnormalities are found on laboratory evaluation and the patient is asymptomatic

Document the incidental finding, the assessment performed, and the monitoring plan.

Scenario 5: Splenomegaly in Cats

Splenomegaly in cats presents unique challenges due to the mobile nature of the feline spleen and the different spectrum of diseases.

Common causes of splenomegaly in cats include:

• Lymphoma (most common neoplastic cause)
• Mast cell disease (systemic mastocytosis or mast cell tumor)
• Extramedullary hematopoiesis
• Infectious diseases (feline infectious peritonitis, mycobacteriosis, histoplasmosis)
• Amyloidosis
• Hyperthyroidism (mild splenomegaly)

The diagnostic approach in cats follows the same algorithm but with attention to species-specific considerations:

• FNA is well-tolerated in cats and often diagnostic for lymphoma and mast cell disease
• Core biopsy carries higher risk in cats due to smaller splenic size
• Coagulation testing should include feline-specific reference ranges
• Infectious disease testing should be performed based on geographic location and exposure history

The Merck Veterinary Manual provides species-specific guidance for splenomegaly evaluation in cats.

Common Failure Patterns and Prevention

Failure Pattern 1: Delayed Diagnosis Due to Inadequate Palpation

Prevention: Perform splenic palpation in every abdominal examination. Use both lateral and dorsal recumbency. In obese patients or those with tense abdominal musculature, use ultrasound for initial assessment. Document splenic palpation findings in every medical record.

Failure Pattern 2: Sampling Without Coagulation Testing

Prevention: Establish a protocol requiring coagulation testing before any splenic sampling. Use a checklist or electronic medical record prompt to ensure testing is performed. Document the coagulation panel results and interpretation before proceeding.

Failure Pattern 3: Inadequate Sample for Diagnosis

Prevention: Use ultrasound guidance for all splenic sampling. Obtain multiple samples from different regions. Have a cytologist or pathologist review the sample immediately for adequacy if possible. If FNA is nondiagnostic, proceed to core biopsy or surgical excision.

Failure Pattern 4: Failure to Monitor for Hemorrhage After Sampling

Prevention: Establish a monitoring protocol for all patients undergoing splenic sampling. Monitor vital signs every 4 hours for 12 hours, then every 6 hours for 12 hours. Document packed cell volume before and after sampling. Provide clear instructions to owners for monitoring at home if the patient is discharged.

Failure Pattern 5: Delayed Surgical Referral

Prevention: Establish clear criteria for surgical referral. Refer when the mass is large, adherent, or located at the splenic hilus. Refer when there is concern for metastatic disease or vascular invasion. Refer when the patient has concurrent medical conditions that increase anesthetic risk. Document the referral decision and communication with the surgeon.

Welfare and Safety Considerations

Pain Assessment and Management

Splenomegaly can cause significant abdominal pain, particularly when the splenic capsule is stretched or when there is splenic infarction or torsion. Use validated pain scoring systems appropriate for the species:

• Glasgow Composite Measure Pain Scale for dogs
• Colorado State University Feline Acute Pain Scale for cats

Provide analgesia before and after splenic sampling or surgery. Multimodal analgesia including opioids, nonsteroidal anti-inflammatory drugs, and local anesthetics is recommended. The American College of Veterinary Anesthesia and Analgesia provides guidelines for perioperative pain management.

Anesthetic Considerations

Patients with splenomegaly may have underlying disease that affects anesthetic risk. Consider the following:

• Patients with hemoabdomen are hemodynamically unstable and require aggressive fluid resuscitation before anesthesia
• Patients with splenic torsion may have electrolyte abnormalities and acid-base disturbances
• Patients with neoplastic disease may have paraneoplastic syndromes affecting coagulation or metabolism
• Patients with immune-mediated disease may be on immunosuppressive therapy affecting wound healing

Select anesthetic drugs based on the patient's cardiovascular status. Propofol and sevoflurane are commonly used for induction and maintenance. Ketamine may be used for patients with hypotension. The American Animal Hospital Association provides guidelines for anesthetic management.

Postoperative Monitoring

After splenectomy, monitor for:

• Hemorrhage (tachycardia, hypotension, abdominal distension, decreasing packed cell volume)
• Pancreatitis (vomiting, anorexia, abdominal pain, elevated amylase and lipase)
• Infection (fever, surgical site swelling or discharge)
• Thromboembolism (dyspnea, hind limb paresis, sudden death)

Document vital signs, pain scores, and surgical site integrity at regular intervals. Provide clear discharge instructions to owners including signs of complications and when to seek emergency care.

Frequently Asked Questions

What is the most common cause of splenomegaly in dogs?

The most common causes of splenomegaly in dogs include nodular hyperplasia, extramedullary hematopoiesis, hematoma, hemangiosarcoma, and lymphoma. The relative frequency varies with breed, age, and geographic location. The Merck Veterinary Manual provides a comprehensive list of differential diagnoses for splenomegaly in dogs.

How is splenomegaly diagnosed in cats?

Splenomegaly in cats is diagnosed by physical examination, abdominal radiography, and abdominal ultrasound. The feline spleen is more mobile than the canine spleen and may be located in the right abdomen. Ultrasound is the preferred imaging modality for characterizing splenomegaly in cats.

What is the risk of bleeding after splenic fine-needle aspiration?

The risk of clinically significant bleeding after splenic FNA is low but not zero. The risk is increased in patients with coagulopathy, thrombocytopenia, or von Willebrand disease. Coagulation testing should be performed before FNA, and the patient should be monitored for 24 hours after the procedure.

When is splenectomy indicated for splenomegaly?

Splenectomy is indicated for splenic torsion, traumatic splenic rupture, hemoabdomen from splenic mass rupture, and benign splenic masses that cause clinical signs. Splenectomy may also be indicated for immune-mediated diseases that are refractory to medical management.

What is the prognosis for dogs with splenic hemangiosarcoma?

The prognosis for dogs with splenic hemangiosarcoma is poor. Median survival time after splenectomy alone is 2 to 3 months. Adjuvant chemotherapy may extend survival to 6 to 9 months. The prognosis is worse for dogs with metastatic disease at the time of diagnosis.

Can splenomegaly be managed medically?

Medical management of splenomegaly depends on the underlying cause. Infectious causes are treated with appropriate antimicrobial therapy. Immune-mediated causes are treated with immunosuppressive drugs. Congestive causes are treated by addressing the underlying cardiac or hepatic disease.

What breeds are at increased risk for splenic torsion?

Large-breed dogs with deep chests are at increased risk for splenic torsion. Breeds at increased risk include Great Danes, German Shepherd Dogs, Irish Setters, and Standard Poodles. Splenic torsion is rare in cats and small-breed dogs.

How is splenic torsion diagnosed?

Splenic torsion is diagnosed by abdominal ultrasound, which shows a markedly enlarged spleen with a hyperechoic parenchyma and absence of blood flow on Doppler examination. CT may be used to confirm the diagnosis and assess for concurrent gastric dilatation-volvulus. The Journal of Small Animal Practice published a case series describing the ultrasound findings in splenic torsion.

Related Veterinary Guides

• Veterinary Science
• Livestock Nutrition And Feed Management A Cross Species Decision Framework
• Veterinary Clinical Methods Procedures Surgical Interventions
• Blood Gas Analysis And Acid Base Interpretation In Veterinary Patients
• How Ai Is Changing Veterinary Care

References and Further Reading

• www.avma.org
• www.aaha.org
• www.acvaa.org
• Merck Veterinary Manual. Merck Veterinary Manual.
• Animal Health and Welfare. World Organisation for Animal Health.
• Splenomegaly.. Journal of the American Veterinary Medical Association, 1969.
• [Splenotomography].. La Nouvelle presse medicale, 1973.
• Suspected Phenobarbital-Induced Pseudolymphoma in a Dog.. Journal of veterinary internal medicine, 2017.
• What is your diagnosis?Splenic torsion.. The Journal of small animal practice, 1999.
• Acute undifferentiated leukaemia in a dog.. Australian veterinary journal, 2014.
• Gastric Dilatation Organoaxial Volvulus in a Dog.. Journal of the American Animal Hospital Association, 2020.
• Validation of Wireless Harness for Measuring Respiratory Rate, Heart Rate, and Body Temperature in Hospitalized Dogs. Veterinary Sciences, 2025.

This article is educational and is not a substitute for veterinary diagnosis or treatment. Contact a veterinarian for advice about an individual animal.